Balaji Amines, a prominent Indian manufacturer of aliphatic amines, saw its shares hit a 20% upper circuit limit on the Bombay Stock Exchange, reaching ₹1,622.55 per share. This surge followed the company's announcement of its Q4FY26 results, which revealed a 57.7% year-on-year increase in net profit, amounting to ₹632 crore, compared to ₹400.6 crore in the previous year. Revenue from operations also grew by 12%, totaling ₹3,947.8 crore, up from ₹3,527.2 crore year-on-year. The company's total income for the quarter was reported at ₹4,025.2 crore, an increase from ₹3,607.5 crore in the same quarter last year. Balaji Amines' total expenses rose slightly to ₹3,166.6 crore from ₹3,068.2 crore. The board has recommended a final dividend of ₹11 per equity share, which represents a 550% payout on the face value of ₹2 per share, pending approval at the upcoming Annual General Meeting. Established in 1988, Balaji Amines has developed proprietary amine technology, allowing it to produce high-quality products for various industries, including pharmaceuticals and specialty chemicals, and has gained a strong foothold in international markets.